Abrocitinib 'safe, effective' for atopic dermatitis, industry study finds

Researchers report on results from a phase three trial that includes adolescents

The investigational drug abrocitinib is safe and effective for treating moderate to severe atopic dermatitis in adolescents and adults, an industry trial shows.